SkinVision Blog

Useful information on skin cancer, melanoma, skin moles, and how to keep your skin healthy. For medical information about skin cancer, check our library.

Melanoma: The current situation in New Zealand

New Zealand has, together with Australia, the highest melanoma incidence in the world. The combination of skin type and UV impact from the sun put the inhibitors of New Zealand at high risk. So let’s take a closer look at the current melanoma situation in NZ.

Read More »

Why is skin cancer so common in Australia?

Australia has a confluence of factors that put the population at risk of skin cancer. According to Cancer Council Australia, there are more than 750,000 people treated for one or more non-melanomas in Australia each year. Currently, two in three Australians will be diagnosed with some form of skin cancer before the age of 70. In fact, it was estimated that 15,229 new cases of melanoma alone would be diagnosed in 2019 (Australian Institute of Health and Welfare).

Read More »

Press Release (in Dutch): Mijlpaal voor SkinVision, drie belangrijke certificaten behaald

SkinVision, de toonaangevende app voor vroege huidkankerdetectie, heeft onlangs drie belangrijke ISO certificaties mogen ontvangen. De British Standards Institution (BSI), heeft SkinVision onderscheiden met ISO 13485:2016 voor het kwaliteitsmanagement systeem wat bij SkinVision in werking is. Daarnaast heeft het BSI het bedrijf ook onderscheiden met ISO27001:2013 voor het management van informatieveiligheid. Bij deze laatste onderscheiding heeft SkinVision ook de Nederlandse nationale standaard NEN 7510:2017 ontvangen. Deze Nederlandse standaard bevat extra eisen die aansluiten bij de ISO27001:2013, die specifiek gericht zijn op zorgaanbieders in Nederland (waar SkinVision gevestigd is).

Read More »

Milestone for SkinVision: Three Important Certifications Achieved

SkinVision, the leading app for early skin cancer detection, recently achieved three important ISO certifications. The British Standards Institution (BSI), awarded SkinVision ISO 13485:2016 for its quality management system. Additionally, BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510:2017, which includes additional requirements to ISO 27001:2013, specifically for healthcare providers in the Netherlands, where SkinVision is based. 

Read More »

New Study Finds SkinVision Detects 95% of Skin Cancer 

Amsterdam, 12 September 2019​ – An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer. 

Read More »